510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K213858Substantially Equivalent

LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus

Diasorin Inc., Stillwater MN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K213858 is the FDA 510(k) clearance record for LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus, a class II device, cleared for DiaSorin, Inc. on under FDA product code NXO (Calprotectin, Fecal). FDA's definition for product code NXO reads: "The device is used for the measurement, in human stool, of fecal calprotectin, a neutrophilic protein that is a marker of mucosal inflammation. The device can be used as an aid in the diagnosis of inflammatory bowel disease (ibd), crohn's...". FDA records list 74 510(k) clearances for DiaSorin, Inc., from to . As of , FDA records show one recall naming K213858.

Clearance record

Decision date
Received
(228 days to decision)
Product code
NXO Calprotectin, Fecal
Regulation
21 CFR 866.5180
Device class
Class II
Review panel
Immunology
Applicant
DiaSorin, Inc. 1951 Northwestern Ave., Stillwater MN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NXO

Trailing 12 months

FDA records hold no clearances under product code NXO in the trailing twelve months.

FDA records show no clearances under product code NXO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code NXO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260